ORPH
Income statement / Annual
Last year (2020), Orphazyme A/S's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Orphazyme A/S's net income was -$633.25 M.
See Orphazyme A/S,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$261.14 M
|
$285.41 M
|
$154.95 M
|
$99.05 M
|
$55.82 M
|
$45.87 M
|
| General & Administrative
Expenses |
$342.20 M
|
$49.84 M
|
$75.33 M
|
$31.99 M
|
$7.70 M
|
$7.22 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$342.20 M
|
$49.84 M
|
$75.33 M
|
$31.99 M
|
$7.70 M
|
$7.22 M
|
| Other Expenses |
$5.20 M |
$699,000.00 |
$1.37 M |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$608.53 M |
$335.95 M |
$231.65 M |
$131.04 M |
$63.52 M |
$53.09 M |
| Cost And Expenses |
$608.53 M |
$335.95 M |
$231.65 M |
$131.04 M |
$63.52 M |
$53.09 M |
| Interest Income |
$45,000.00 |
$316,000.00 |
$5,000.00 |
$0.00 |
$2,000.00 |
$0.00 |
| Interest Expense |
$14.11 M |
$4.80 M |
$3.45 M |
$647,000.00 |
$71,000.00 |
$0.00 |
| Depreciation &
Amortization |
$5.20 M
|
$3.80 M
|
$1.37 M
|
$627,000.00
|
$706,000.00
|
$554,000.00
|
| EBITDA |
-$615.85 M
|
-$334.39 M
|
-$230.28 M
|
-$130.43 M
|
-$62.66 M
|
-$52.85 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$14.11 M
|
-$4.80 M
|
-$3.45 M
|
-$647,000.00
|
-$71,000.00
|
$0.00
|
| Income Before Tax |
-$635.16 M |
-$343.00 M |
-$235.10 M |
-$131.70 M |
-$63.44 M |
-$53.40 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.92 M |
-$5.50 M |
-$5.50 M |
-$5.50 M |
-$5.50 M |
-$5.69 M |
| Net Income |
-$633.25 M |
-$337.50 M |
-$229.60 M |
-$126.20 M |
-$57.94 M |
-$47.71 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-22.32 |
-16.87 |
-11.5 |
-10.46 |
-5.65 |
-4.66 |
| EPS Diluted |
-22.32 |
-16.87 |
-11.5 |
-10.46 |
-5.65 |
-4.66 |
| Weighted Average Shares
Out |
$28.37 M
|
$20.00 M
|
$19.97 M
|
$12.06 M
|
$10.25 M
|
$10.25 M
|
| Weighted Average Shares
Out Diluted |
$28.37 M
|
$20.00 M
|
$19.97 M
|
$12.06 M
|
$10.25 M
|
$10.25 M
|
| Link |
|
|
|
|
|
|
